Template:Antithrombotics: Difference between revisions
From WikiMD's Wellness Encyclopedia
CSV import |
en>Jonesey95 m Fix Linter errors related to text color in dark mode; this generally works but may cause problems, in which case revert or try specifying a different CSS value. |
||
| Line 106: | Line 106: | ||
** [[Sulodexide]] | ** [[Sulodexide]] | ||
| group2 = [[Direct Xa inhibitor]]s ("xabans") | | group2 = [[Direct factor Xa inhibitors|Direct Xa inhibitor]]s ("xabans") | ||
| list2 = | | list2 = | ||
* [[Apixaban]] | * [[Apixaban]] | ||
| Line 124: | Line 124: | ||
** [[Bivalirudin]] | ** [[Bivalirudin]] | ||
** [[Desirudin]] | ** [[Desirudin]] | ||
** [[Lepirudin]] | ** [[Lepirudin]]<sup>‡</sup> | ||
* [[Direct thrombin inhibitor#Univalent|Univalent]]: [[Argatroban]] | * [[Direct thrombin inhibitor#Univalent|Univalent]]: [[Argatroban]] | ||
* [[Dabigatran]] | * [[Dabigatran]] | ||
| Line 134: | Line 134: | ||
| group5 = Other | | group5 = Other | ||
| list5 = | | list5 = | ||
* [[Abelacimab]] | |||
* [[Antithrombin|Antithrombin III]] | * [[Antithrombin|Antithrombin III]] | ||
* [[Defibrotide]] | * [[Defibrotide]] | ||
* [[Nafamostat]] | |||
* [[Protein C]] | * [[Protein C]] | ||
** [[Drotrecogin alfa]]<sup>‡</sup> | ** [[Drotrecogin alfa]]<sup>‡</sup> | ||
| Line 146: | Line 148: | ||
| list3 = | | list3 = | ||
* [[Plasminogen activator]]s: [[Recombinant tissue plasminogen activators|r-tPA]] | * [[Plasminogen activator]]s: [[Recombinant tissue plasminogen activators|r-tPA]] | ||
** [[Alteplase]] | ** [[Alteplase]]<sup>#</sup> | ||
** [[Reteplase]] | ** [[Reteplase]] | ||
** [[Tenecteplase]] | ** [[Tenecteplase]] | ||
| Line 156: | Line 158: | ||
* [[Monteplase]] | * [[Monteplase]] | ||
* [[Streptokinase]]<sup>#</sup> | * [[Streptokinase]]<sup>#</sup> | ||
* Other [[serine endopeptidase]]s: [[Ancrod]] | * Other [[serine endopeptidase]]s: [[Ancrod]]<sup>‡</sup> | ||
* [[Brinase]] | * [[Brinase]] | ||
* [[Fibrinolysin]] | * [[Fibrinolysin]] | ||
| Line 166: | Line 168: | ||
* [[Oxalate]] | * [[Oxalate]] | ||
| belowstyle = | | belowstyle = padding: 0px; | ||
| below = {{PharmNavFootnote}} | | below = {{PharmNavFootnote}} | ||
| Line 173: | Line 175: | ||
[[Category:Drug templates by ATC]] | [[Category:Drug templates by ATC]] | ||
</noinclude> | </noinclude> | ||
Revision as of 20:08, 4 February 2025
| Antithrombotics (thrombolytics, anticoagulants and antiplatelet drugs) (B01) | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
